Uncovering Clinical Features of De Novo Philadelphia Positive Myelodysplasia
Myelodysplastic syndrome (MDS) is cytogenetically heterogeneous and retains variable risk for acute myeloid leukemia transformation. Though not yet fully understood, there is an association between genetic abnormalities and defects in gene expression. The functional role for infrequent cytogenetic a...
Saved in:
Main Authors: | Aristides Armas, Chen Chen, Martha Mims, Gustavo Rivero |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2017/5404131 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Temozolomide-Induced Myelodysplasia
by: Ethan A. Natelson, et al.
Published: (2010-01-01) -
Introduction to the Review Series on Myelodysplasia
by: Moshe Mittelman
Published: (2025-01-01) -
Myelodysplasia and Mast Cell Leukemia with t(9;22)
by: Kathryn J. Lago, et al.
Published: (2017-01-01) -
Acquired Myelodysplasia or Myelodysplastic Syndrome: Clearing the Fog
by: Ethan A. Natelson, et al.
Published: (2013-01-01) -
A Case of Philadelphia Chromosome Positive Myeloproliferative Neoplasm in a Pregnant Woman with Unusual Primary Myelofibrosis Features
by: Jason Koshy, et al.
Published: (2013-01-01)